Bellerophon Therapeutics, Inc. Annual Return On Assets in % from 2015 to 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Bellerophon Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2015 to 2022.
  • Bellerophon Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2023 was -92.2 %, a 4.6% increase year-over-year.
  • Bellerophon Therapeutics, Inc. annual Return On Assets for 2022 was -132 %, a 156% decline from 2021.
  • Bellerophon Therapeutics, Inc. annual Return On Assets for 2021 was -51.7 %, a 5.19% increase from 2020.
  • Bellerophon Therapeutics, Inc. annual Return On Assets for 2020 was -54.5 %, a 22.9% increase from 2019.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -132 -80.5 -156% Jan 1, 2022 Dec 31, 2022
2021 -51.7 +2.83 +5.19% Jan 1, 2021 Dec 31, 2021
2020 -54.5 +16.2 +22.9% Jan 1, 2020 Dec 31, 2020
2019 -70.7 -81.1 -776% Jan 1, 2019 Dec 31, 2019
2018 10.5 +185 Jan 1, 2018 Dec 31, 2018
2017 -174 -87.7 -101% Jan 1, 2017 Dec 31, 2017
2016 -86.6 -4.06 -4.92% Jan 1, 2016 Dec 31, 2016
2015 -82.6 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.